We could confirm our previous results showing that during pancreatic carcinogenesis from PanIN lesions to invasive cancer, infiltrating CD11b+ cells exhibit an increase in the M2 markers CD204, whereas the M1 markers MHCII was not significantly affected (Figure 1A). The gene discussed is MSR1; the disease is cancer.